Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis

NCT03122873 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2017-08-30

No results posted yet for this study

Summary

The study is designed to quantitate McArdle's sign, an increase in measurable weakness with neck flexion described in patients with multiple sclerosis, and to determine whether it is or is not specific for multiple sclerosis.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Brian Weinshenker, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03122873 on ClinicalTrials.gov